BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33918312)

  • 1. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
    Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells.
    Chen GS; Chen SY; Liu ST; Hsieh CC; Lee SP; Huang SM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
    Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
    Zhao Y; Zhu S
    Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
    Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
    Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
    Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
    Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions.
    Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L
    Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
    Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
    J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.
    Karamanakos PN; Trafalis DT; Papachristou DJ; Panteli ES; Papavasilopoulou M; Karatzas A; Kardamakis D; Nasioulas G; Marselos M
    J BUON; 2017; 22(5):1227-1232. PubMed ID: 29135106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway.
    Ren Y; Lin Y; Chen J; Jin Y
    Biol Pharm Bull; 2021; 44(10):1557-1564. PubMed ID: 34602566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Status Determines the Cytotoxicity of Ascorbic Acid in Human Oral Normal and Cancer Cells.
    Huang WZ; Liu TM; Liu ST; Chen SY; Huang SM; Chen GS
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression.
    Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
    Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
    Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes.
    Hassani S; Ghaffari P; Chahardouli B; Alimoghaddam K; Ghavamzadeh A; Alizadeh S; Ghaffari SH
    Biomed Pharmacother; 2018 Mar; 99():561-569. PubMed ID: 29902866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Rieber M
    Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.